#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Gastroenterology and Hepatology / 2023 - 5

Subcutaneous infliximab – treatments and new possibilities after clinical practice

Czech version

Published in: Gastroent Hepatol 2023; 77(5): 455-458
Category:

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Colorectal cancer screening in the Czech Republic
Editorial
Anemic patient
Results from the evaluation of colorectal cancer screening in the Czech Republic
Trends in premature mortality from digestive system cancers in Slovakia in the years 2011–2020: 8 diagnoses over 10 years
Mixed adenoneuroendocrine carcinoma of the stomach – a case report
Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity
Konsenzus Pracovnej skupiny pre IBD Slovenskej gastroenterologickej spoločnosti
Urolithiasis in patients with inflammatory bowel disease – possibilities of prevention and metabolic influence
The selection from international journals
Anniversary of Prof. Miroslav Zavoral, MD, PhD.
Current possibilities of using tofacitinib in ulcerative colitis in domestic practice
Desired IBD treatment goals and how to achieve them
Registry – okno do skutečného světa klinické praxe
Nejdůležitějším cílem je kvalita života
Kreditovaný autodidaktický test: Gastrointestinální onkologie
Article was published in

Gastroenterology and Hepatology

Issue 5
2023 Issue 5
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#